You are here
Home 🌿 Marijuana Politics 🌿 Wisconsin Senate overwhelmingly passes marijuana extract bill 🌿Wisconsin Senate overwhelmingly passes marijuana extract bill
Warning message
The subscription service is currently unavailable. Please try again later.The state Senate has overwhelmingly approved a bill that would make it legal to use a marijuana extract to treat seizures.
The measure legalizes possession of cannabidiol oil with a doctor's certification. The chamber adopted the bill on a 31-1 vote Wednesday. Republican Sen. Duey Stroebel was the only senator to vote against it.
Parents of children who suffer from seizures say cannabidiol oil, which doesn't produce a high, can ease symptoms.
Democratic Sen. Chris Larson argued the bill doesn't go far enough, pointing out that importing the oil into Wisconsin would remain illegal. He tried to amend the bill to allow production of the oil in the state but Republicans refused to revise the measure.
The bill goes next to the Assembly.
420 Intel is Your Source for Marijuana News
420 Intel Canada is your leading news source for the Canadian cannabis industry. Get the latest updates on Canadian cannabis stocks and developments on how Canada continues to be a major player in the worldwide recreational and medical cannabis industry.
420 Intel Canada is the Canadian Industry news outlet that will keep you updated on how these Canadian developments in recreational and medical marijuana will impact the country and the world. Our commitment is to bring you the most important cannabis news stories from across Canada every day of the week.
Marijuana industry news is a constant endeavor with new developments each day. For marijuana news across the True North, 420 Intel Canada promises to bring you quality, Canadian, cannabis industry news.
You can get 420 Intel news delivered directly to your inbox by signing up for our daily marijuana news, ensuring you’re always kept up to date on the ever-changing cannabis industry. To stay even better informed about marijuana legalization news follow us on Twitter, Facebook and LinkedIn.